Montular kids chewable tablets 5 mg No. 30




Montular Kids is a medicine for systemic use in obstructive airway diseases.
Indications for use
as an additional treatment for bronchial asthma in patients aged 6 to 14 years with persistent mild to moderate asthma, which is not adequately controlled by inhaled corticosteroids, as well as with insufficient clinical control of asthma with short-acting β-adrenergic agonists used as needed; as an alternative treatment method instead of low doses of inhaled corticosteroids in patients aged 6 to 14 years with persistent mild asthma, who have not had a recent serious attack of bronchial asthma requiring the use of oral corticosteroids, and who cannot use inhaled corticosteroids; prevention of asthma, the dominant component of which is exercise-induced bronchospasm, in patients aged 6 to 14 years.Warehouse
Each chewable tablet contains montelukast sodium equivalent to 5 mg montelukast; excipients: microcrystalline cellulose (PH 112), hydroxypropylcellulose, croscarmellose sodium, red iron oxide (E 172), aspartame (E 951), cherry flavoring 501027AP0551, mannitol (E 421), magnesium stearate.Contraindication
Hypersensitivity to any of the components of the drug.
Method of application
The recommended dose for children aged 6 to 14 years is 1 chewable tablet (5 mg) per day, taken in the evening. The drug should be taken 1 hour before or 2 hours after a meal. No dose adjustment is necessary for this age group.
Application features
Patients should be advised that Montular® Kids for oral administration should not be used to treat acute asthma attacks and that they should always carry appropriate rescue medication with them. In the event of an acute attack, a short-acting inhaled β-agonist should be used. Patients should consult their doctor as soon as possible if they require more inhalations of short-acting β-agonists than usual.
Pregnant women
Available data from published prospective and retrospective cohort studies of montelukast use in pregnant women evaluating major birth defects in offspring have not established a drug-related risk. The available studies have methodological limitations, including small sample sizes, retrospective data collection in some cases, and inconsistent comparison groups.
Children
The drug is used in children aged 6 to 14 years.
Drivers
Montelukast has no or negligible influence on the ability to drive and use machines. However, drowsiness or dizziness have been reported by patients.
Overdose
The most frequently observed adverse reactions were consistent with the safety profile of the drug and included abdominal pain, drowsiness, thirst, headache, vomiting, and psychomotor hyperactivity.
Side effects
From the blood and lymphatic system: tendency to increased bleeding, thrombocytopenia.
Immune system disorders: hypersensitivity reactions, including anaphylaxis, eosinophilic infiltration of the liver.
Psychiatric: hallucinations, disorientation, suicidal thoughts and behavior (suicidality), obsessive-compulsive disorders, dysphemia.
Nervous system: dizziness, lethargy, paresthesia/hypoesthesia, convulsions.
Storage conditions
Store in the original packaging at a temperature not exceeding 25°C.
Keep out of reach of children.
There are no reviews for this product.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.